Abstract:The 1999 Review of biotechnology regulation required the policy community of human genetics to introduce a new and open approach to governance. In implementing this policy of self-reform, the policy community is obliged to reconcile conflicting political demands from the policy networks of civil society, science and industry as it seeks to establish and maintain the legitimacy of the new regulatory apparatus. Drawing on documentary and interview evidence, this article explores how policy community change may be limited and structured by its existing culture and policy networks in ways not predicted by existing theory. Spanish La Evaluación de 1999 de la regulación de biotecnología pedía a la comunidad política de genética humana introducir un acercamiento nuevo y abierto de forma de gobierno. Al implementar esta política de reforma propia, la comunidad política está obligada a reconciliar las demandas políticas conflictivas de las redes políticas de la sociedad civil, ciencia e industria ya que busca establecer y mantener la legitimidad del nuevo aparato regulador. Basándonos en documentales y evidencia de entrevista, este artículo explora cómo el cambio de la comunidad política puede ser limitado y estructurado por su existente cultura y redes políticas de maneras no previstas por la teoría existente. French En 1999, la Revue de la régulation de la biotechnologie exigeait que la communauté politique de la génétique humaine introduise une nouvelle approche de la gouvernance. En mettant en place cette politique d'auto-réforme, la communauté politique est obligée de réconcilier les exigences politiques contradictoires des réseaux de politique de la société civile et de l'industrie, car elle cherche à établir et à maintenir la légitimité du nouvel appareil régulateur. Se basant sur des preuves tirées de documents et d'entrevues, cet article étudie la façon dont le changement de la communauté politique peut être limité et structuré par sa culture et ses réseaux politiques existants d'une façon que la théorie actuelle n'avait pas prévue.

Molecular Biology or Molecular Politics? The Production of Scientific Consensus on the Hazards of Recombinant DNA Technology

Who Should Be Driving US Science Policy?

Ethical and social aspects of experimental gene manipulation

When experts matter: Variations in consensus messaging for vaccine and genetically modified organism safety

Are null segregants new combinations of heritable material and should they be regulated?

Revolution versus evolution?: Understanding scientific and technological diffusion in synthetic biology and their implications for biosecurity policies

[The critical scientists' voice]

Concerns regarding the deterioration of objectivity in molecular biology

Untangling the Debate Over Genetically Modified Foods

Biotechnology and the new right: neoconservatism's red menace

The emerging international regulatory framework for biotechnology

Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR

Biotechnology, ethics, and the structure of agriculture

Mammalian-transmissible H5N1 influenza: the dilemma of dual-use research

Navigating the 'moral hazard' argument in synthetic biology's application

The Myriad Decision at 10

Tempest in a Tea Pot: How did the Public Conversation on Genetically Modified Crops Drift so far from the Facts?

Change in the policy community of human genetics: a pragmatic approach to open governance

Society and Nuclear Energy: What Is the Role for Radiological Protection?

Governance of Gene-edited Plants: Insights from the History of Biotechnology Oversight and Policy Process Theory

Review on: Public Perception of Biotechnology on Genetically Modified Crops, Bio Policy and Intellectual Property Rights